We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals

17 hedge funds and large institutions have $91.7K invested in Sonoma Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

465% more capital inflows, than outflows

Capital inflows: $59.3K | Capital outflows: $10.5K

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

21% more funds holding

Funds holding: 14 → 17 (+3)

1.24% more ownership

Funds ownership: 1.05% → 2.29% (+1.2%)

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SNOA Hedge Fund Activity: Q2 2024 in Review

17 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q2 2024, worth a combined $91.7K — up 236% from $27.3K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SNOA positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $34.7K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $7.66K sold.

  • 17 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q2 2024, up from 14 in Q1 2024.
  • Funds reported $91.7K of Sonoma Pharmaceuticals stock for Q2 2024, up 236% quarter-over-quarter.
  • 5 funds opened new Sonoma Pharmaceuticals positions in Q2 2024 and 2 closed out, a net change of +3 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q2 2024 was Citadel Advisors, an estimated $34.7K added.
  • The largest Sonoma Pharmaceuticals seller in Q2 2024 was Susquehanna International Group, an estimated $7.66K sold.

Based on aggregated 13F filings for Q2 2024.